Related Experiment Video
Updated: Aug 29, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Combined aortic and mitral valve repair
Toshinobu Kazui1, Hajime Kin, Hiroshi Izumoto
1Department of Cardiovascular Surgery, Memorial Heart Center, Iwate Medical University, 1-2-1 Chuoudori, Morioka City, Iwate, Japan. t-kazui@pf6.so-net.ne.jp
Insights
Double valve repair for degenerative valvular disease offers excellent short-term outcomes. This study shows a 100% survival rate and improved heart function after concomitant mitral and aortic valve repair.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Disease
Background:
- Degenerative valvular disease affects multiple heart valves.
- Concomitant mitral and aortic valve disease often necessitates complex surgical intervention.
Purpose of the Study:
- To evaluate the safety and efficacy of concomitant mitral and aortic valve repair.
- To assess early clinical and echocardiographic outcomes of double valve repair.
Main Methods:
- Retrospective review of surgical reports and clinical data for six patients undergoing double valve repair.
- Analysis of preoperative and postoperative New York Heart Association (NYHA) classification scores.
- Intraoperative transesophageal echocardiography to assess left ventricular dimensions.
Main Results:
- No surgical complications or 30-day mortality.
- Significant improvement in NYHA classification (2.2 to 1.0, p=0.03).
- Reduction in left ventricular end-diastolic diameter (6.0 to 4.7 cm) and end-systolic diameter (3.7 to 3.1 cm).
Conclusions:
- Concomitant mitral and aortic valve repair is a viable alternative to replacement in selected patients.
- The procedure demonstrated favorable early outcomes with no major complications.
- Further long-term studies with larger cohorts are warranted to confirm durability.
Abstract:
Six patients, median age 63.3 years (range, 54 to 68 years), underwent concomitant mitral and aortic valve repair from January 2000 to August 2001. Surgical reports and general clinical data were reviewed retrospectively. All patients had degenerative valvular disease, although one patient also had annuloaortic ectasia. There were no surgical complications. The 30 day survival rate was 100%, and the New York Heart Association classification score improved from 2.2 (range, 1 to 2) preoperative, to 1.0 (all patients) postoperatively (p = 0.03) As measured by intraoperative transesophageal echocardiography, the left ventricular end-diastolic diameter decreased from 6.0 cm (range, 5.4 to 6.3 cm) to 4.7 cm (range, 4.0 to 5.2 cm) and the left ventricular end-systolic diameter decreased from 3.7 cm (range, 3.4 to 4.1cm) to 3.1 cm (range, 2.9 to 3.7 cm). No patient developed endocarditis, thromboembolism or hemorrhage. There was no valve related morbidity during a 1 year follow up. Double valve repair is an acceptable alternative to valve replacement in selected patients with some types of valvular disease. Longer term follow up with greater numbers of patients is needed.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse I: Introduction
Mitral Stenosis I: Introduction

